Taking stock of gene therapy for cystic fibrosis

AUTOR(ES)

Stern, Myra

FONTE

BioMed Central

RESUMO

The identification of the cystic fibrosis (CF) gene opened the way for gene therapy. In the ten years since then, proof of principle in vitro and then in animal models in vivo has been followed by numerous clinical studies using both viral and non-viral vectors to transfer normal copies of the gene to the lungs and noses of CF patients. A wealth of data have emerged from these studies, reflecting enormous progress and also helping to focus and define key difficulties that remain unresolved. Gene therapy for CF remains the most promising possibility for curative rather than symptomatic therapy.

Documentos Relacionados

• Gene therapy for cystic fibrosis.
• Status of gene therapy for cystic fibrosis lung disease
• Adeno-associated virus for cystic fibrosis gene therapy
• Gene therapy for cystic fibrosis: challenges and future directions.
• Gene transfer for cystic fibrosis